Skip to main content

Market Overview

Sage Therapeutics (NASDAQ: SAGE)

54.88 -3.92 (-6.67%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
Pre-Market
EPS:
REV:




Q4 2021
Pre-Market
EPS:
REV:




Q3 2021
Pre-Market
EPS:
REV:
-2.03
1.639M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-2.44
2.286M
-1.91
2M
-1.64
1.583M
14.14%
-20.85%
Q4 2020
Pre-Market
EPS:
REV:
-3.25
1.96M
-0.35
55.34M
18.19
1.109B
5297.14%
1903.98%
Q3 2020
Pre-Market
EPS:
REV:
-3.48
3.57M
-2.39
1.86M
-2.03
1.639M
15.06%
-11.88%
Q2 2020
Pre-Market
EPS:
REV:
-3.28
873K
-2.66
890K
-2.08
1.089M
21.8%
22.36%
Q1 2020
Pre-Market
EPS:
REV:
-3.37
465K
-3.14
2.8M
-2.44
2.286M
22.29%
-18.36%
Q4 2019
Pre-Market
EPS:
REV:
-3.38
273K
-3.61
3.68M
-3.25
1.96M
9.97%
-46.74%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!